Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report) was the target of a large decrease in short interest in June. As of June 15th, there was short interest totalling 1,790,000 shares, a decrease of 8.7% from the May 31st total of 1,960,000 shares. Based on an average daily volume of 666,400 shares, the days-to-cover ratio is presently 2.7 days.
Inspire Medical Systems Price Performance
Inspire Medical Systems stock traded down $0.31 during mid-day trading on Wednesday, hitting $133.94. 305,987 shares of the company’s stock traded hands, compared to its average volume of 597,847. The firm has a 50 day simple moving average of $173.32 and a two-hundred day simple moving average of $191.79. Inspire Medical Systems has a fifty-two week low of $123.27 and a fifty-two week high of $330.00. The stock has a market cap of $3.98 billion, a price-to-earnings ratio of -244.13 and a beta of 1.31.
Inspire Medical Systems (NYSE:INSP – Get Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.63) by $0.29. The business had revenue of $164.01 million during the quarter, compared to the consensus estimate of $161.41 million. Inspire Medical Systems had a negative return on equity of 2.82% and a negative net margin of 2.38%. The company’s quarterly revenue was up 28.2% on a year-over-year basis. During the same quarter last year, the firm posted ($0.53) EPS. On average, research analysts anticipate that Inspire Medical Systems will post 0.16 earnings per share for the current fiscal year.
Analysts Set New Price Targets
View Our Latest Stock Analysis on Inspire Medical Systems
Insider Buying and Selling
In related news, CFO Richard Buchholz sold 15,000 shares of the stock in a transaction that occurred on Wednesday, April 17th. The stock was sold at an average price of $230.03, for a total transaction of $3,450,450.00. Following the completion of the sale, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at approximately $6,503,178.13. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 4.10% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in INSP. Envestnet Asset Management Inc. increased its position in shares of Inspire Medical Systems by 40.8% in the third quarter. Envestnet Asset Management Inc. now owns 30,062 shares of the company’s stock worth $5,965,000 after purchasing an additional 8,711 shares during the period. Stifel Financial Corp increased its position in shares of Inspire Medical Systems by 186.8% in the third quarter. Stifel Financial Corp now owns 11,930 shares of the company’s stock worth $2,367,000 after purchasing an additional 7,770 shares during the period. Northern Trust Corp increased its position in shares of Inspire Medical Systems by 2.4% in the third quarter. Northern Trust Corp now owns 149,275 shares of the company’s stock worth $29,622,000 after purchasing an additional 3,501 shares during the period. Tower Research Capital LLC TRC increased its position in shares of Inspire Medical Systems by 891.7% in the third quarter. Tower Research Capital LLC TRC now owns 3,114 shares of the company’s stock worth $618,000 after purchasing an additional 2,800 shares during the period. Finally, Teza Capital Management LLC bought a new position in shares of Inspire Medical Systems in the third quarter worth $508,000. Institutional investors own 94.91% of the company’s stock.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Featured Stories
- Five stocks we like better than Inspire Medical Systems
- 3 Warren Buffett Stocks to Buy Now
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Why is the Ex-Dividend Date Significant to Investors?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Industrial Products Stocks Investing
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.